ABVC BioPharma reported earnings of $ 0.04 per ABVC share on Nov 10, 2026, falling short of analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.40 |
| Earnings Per Share (Surprise) | $ 0.04 (+$ 0.44) |
| Last Year's EPS | -$ 0.04 |
| EPS YoY Change |
Out of the last 93 earnings reporting periods, ABVC BioPharma beat analysts’ expectations 12 times and fell short of expectations 10 time(s). ABVC BioPharma reported earnings per share of $ 0.04 in the last report surpassing an estimated EPS of -$ 0.40 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.40 | $ 0.04 | -$ 0.05 | |
| Aug 12, 2026 | -$ 0.40 | -$ 0.03 | -$ 0.13 | |
| May 18, 2026 | - | -$ 0.06 | $ 0.04 | |
| Mar 3, 2026 | - | -$ 0.12 | $ 0.04 | |
| Oct 31, 2025 | -$ 0.40 | -$ 0.05 | $ 0.0172 | |
| Aug 13, 2025 | -$ 0.60 | -$ 0.13 | -$ 0.02 | |
| Apr 30, 2025 | -$ 0.50 | $ 0.04 | -$ 0.09 | |
| Apr 15, 2025 | - | $ 0.04 | -$ 0.40 | |
| Mar 11, 2025 | -$ 1.50 | $ 0.0172 | -$ 0.35 | |
| Nov 14, 2024 | -$ 2.00 | -$ 0.02 | -$ 0.82 | |
| Aug 14, 2024 | -$ 1.25 | -$ 0.09 | -$ 0.68 | |
| May 17, 2024 | - | -$ 0.40 | -$ 0.68 | |
| Mar 13, 2024 | -$ 0.50 | -$ 0.35 | -$ 0.60 | |
| Nov 15, 2023 | -$ 0.40 | -$ 0.82 | -$ 0.60 | |
| Aug 15, 2023 | -$ 0.60 | -$ 0.68 | -$ 1.50 | |
| Aug 14, 2023 | -$ 0.60 | -$ 0.68 | -$ 1.10 | |
| May 16, 2023 | -$ 0.05 | -$ 0.60 | -$ 0.60 | |
| May 15, 2023 | -$ 0.50 | -$ 0.60 | -$ 2.00 | |
| Mar 31, 2023 | -$ 0.19 | -$ 1.50 | -$ 0.31 | |
| Nov 14, 2022 | -$ 2.00 | -$ 1.10 | -$ 0.70 |
ABVC BioPharma’s stock was trading at $ 1.02 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, ABVC’s price decreased to $ 0.9921 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | $ 0.04 | $ 1.02 | $ 0.9921 | |
| Aug 12, 2026 | -$ 0.03 | $ 0.985 | $ 0.9594 | |
| May 18, 2026 | -$ 0.06 | $ 1.09 | $ 1.10 | |
| Mar 3, 2026 | -$ 0.12 | $ 1.48 | $ 1.45 | |
| Oct 31, 2025 | -$ 0.05 | $ 2.82 | $ 2.96 | |
| Aug 13, 2025 | -$ 0.13 | $ 2.94 | $ 3.04 | |
| Apr 30, 2025 | $ 0.04 | $ 1.03 | $ 1.03 | |
| Apr 15, 2025 | $ 0.04 | $ 0.92 | $ 0.97 | |
| Mar 11, 2025 | $ 0.0172 | $ 0.632 | $ 0.696 | |
| Nov 14, 2024 | -$ 0.02 | $ 0.535 | $ 0.50 | |
| Aug 14, 2024 | -$ 0.09 | $ 0.707 | $ 0.711 | |
| May 17, 2024 | -$ 0.40 | $ 1.06 | $ 1.08 | |
| Mar 13, 2024 | -$ 0.35 | $ 1.26 | $ 1.20 | |
| Nov 15, 2023 | -$ 0.82 | $ 1.12 | $ 1.59 | |
| Aug 15, 2023 | -$ 0.68 | $ 1.87 | $ 1.94 | |
| Aug 14, 2023 | -$ 0.68 | $ 2.06 | $ 1.91 | |
| May 16, 2023 | -$ 0.60 | $ 7.80 | $ 7.70 | |
| May 15, 2023 | -$ 0.60 | $ 8.27 | $ 6.95 | |
| Mar 31, 2023 | -$ 1.50 | $ 6.20 | $ 6.42 | |
| Nov 14, 2022 | -$ 1.10 | $ 7.22 | $ 7.17 |
ABVC BioPharma released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
ABVC BioPharma beat analysts’ expectations during the last earnings period by
